CAD: coronary artery disease; COPD: chronic obstructive pulmonary
disease; CHF: congestive heart failure; CLD: chronic liver diseases;
Follow-up time:
Control: 6.76(3.56)
Case: 6.80(3.56)
|
CAD: coronary artery disease; COPD: chronic obstructive pulmonary
disease; CHF: congestive heart failure; CLD: chronic liver diseases;
Follow-up time:
Control: 6.76(3.56)
Case: 6.80(3.56)
|
CAD: coronary artery disease; COPD: chronic obstructive pulmonary
disease; CHF: congestive heart failure; CLD: chronic liver diseases;
Follow-up time:
Control: 6.76(3.56)
Case: 6.80(3.56)
|
CAD: coronary artery disease; COPD: chronic obstructive pulmonary
disease; CHF: congestive heart failure; CLD: chronic liver diseases;
Follow-up time:
Control: 6.76(3.56)
Case: 6.80(3.56)
|
CAD: coronary artery disease; COPD: chronic obstructive pulmonary
disease; CHF: congestive heart failure; CLD: chronic liver diseases;
Follow-up time:
Control: 6.76(3.56)
Case: 6.80(3.56)
|
CAD: coronary artery disease; COPD: chronic obstructive pulmonary
disease; CHF: congestive heart failure; CLD: chronic liver diseases;
Follow-up time:
Control: 6.76(3.56)
Case: 6.80(3.56)
|
CAD: coronary artery disease; COPD: chronic obstructive pulmonary
disease; CHF: congestive heart failure; CLD: chronic liver diseases;
Follow-up time:
Control: 6.76(3.56)
Case: 6.80(3.56)
|